⌘K

Login Start Free

Home/Filings/4/0001209191-19-015870

4//SEC Filing

Nogelo Liisa I 4

Accession 0001209191-19-015870

CIK 0001718108other

View on SEC.gov Company Profile

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 6:04 PM ET

Size

5.3 KB

Accession

0001209191-19-015870

Insider Transaction Report

Form 4

Period: 2019-03-01

Surface Oncology, Inc.SURF

General Counsel

Transactions

Award
Stock Option (Right to Buy)
2019-03-01+80,000→ 80,000 total
Exercise: $4.27Exp: 2029-03-01→ Common Stock (80,000 underlying)

Footnotes (1)

[F1]The stock option vests and becomes exercisable in 48 equal monthly installments after February 12, 2019.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Surface Oncology, Inc.

CIK 0001718108

Entity typeother

Related Parties

1

filerCIK 0001745297

Filing Metadata

Form type: 4
Filed: Mar 3, 7:00 PM ET
Accepted: Mar 4, 6:04 PM ET
Size: 5.3 KB

View on SEC.gov